Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Labcorp Holdings Inc. (LH) Market Cap & Valuation Ratios

Labcorp Holdings Inc. (LH) has a market cap of $26.7B, a trailing P/E of 27.2 and a price-to-sales ratio of 1.9, with earnings according to EquiReason's reading of its SEC filings.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

LHLabcorp Holdings Inc.Follow LH — free
Diagnostics & Research · Healthcare
—
Price chart with a free account
Market cap
26.7B
P/E TTM
27.2
Dividend yield
0.9%
52-week
—
Next earnings
28 Oct, in 4 days

Peers

diagnostics & research · nearest by market cap · trailing 12 months
CompanyMkt cap, $BP/EEV/SalesEV/EBITDAFCF yieldRev. growthOp. marginROIC
LH2727.22.314.84.3%+6%10%9%
IQV4634.73.517.74.7%+8%13%9%
WAT45—10.652.10.9%+52%7%2%
IDXX4439.49.927.92.8%+13%32%49%
ILMN4150.39.236.02.3%+5%20%19%
MTD3337.68.628.42.6%+7%28%49%
DGX2724.12.613.65.2%+9%15%11%
GH23—19.6—-1.1%+43%-40%-231%
MEDP1937.26.328.43.6%+20%21%—
RVTY1876.06.825.83.2%+4%12%3%
CRL16—4.748.72.2%-0.7%2%1%
Median of these 1037.67.728.42.7%+9%14%9%

P/E 27.2 vs. a peer median of 37.6; EV/Sales 2.3 vs. 7.7. LH's own P/E sits at the 60th percentile of its history.

Growth vs. price

each dot a company · hover or tap for values
20501000%+10%+20%revenue growth, TTM →P/E (log)LHIQVIDXXILMNMTDDGXMEDPRVTY

WAT and GH and CRL have no P/E (earnings not positive) and are left out · hover or tap a dot for values.

Labcorp Holdings Inc. — questions

What is Labcorp Holdings Inc.'s market cap?
$26.7B.
What is Labcorp Holdings Inc.'s P/E ratio?
27.2 on trailing twelve-month earnings to 2026-06-30.
What is Labcorp Holdings Inc.'s price-to-sales ratio?
1.9.

Every figure on this page comes from Labcorp Holdings Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.